Cookson Peirce & CO Inc Vertex Pharmaceuticals Inc Transaction History

Cookson Peirce & CO Inc

$2.1 Billion
Q3 2024

A detailed history of Cookson Peirce & CO Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cookson Peirce & CO Inc holds 155,081 shares of VRTX stock, worth $63.3 Million. This represents 3.44% of its overall portfolio holdings.

Number of Shares

155,081

Previous 156,169 0.7%

Holding current value

$63.3 Million

Previous $73.2 Million 1.47%

% of portfolio

3.44%

Previous 3.58%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $500,480 - $550,288	-1,088 Reduced 0.7%	155,081 $72.1 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $5.18 Million - $6.4 Million	13,187 Added 9.22%	156,169 $73.2 Million
Q1 2024 Apr 23, 2024	SELL	$407.69 - $446.08 $418,289 - $457,678	-1,026 Reduced 0.71%	142,982 $59.8 Million
Q4 2023 Jan 30, 2024	SELL	$343.0 - $410.68 $992,299 - $1.19 Million	-2,893 Reduced 1.97%	144,008 $58.6 Million
Q3 2023 Nov 07, 2023	BUY	$338.18 - $362.46 $112,613 - $120,699	333 Added 0.23%	146,901 $51.1 Million
Q2 2023 Aug 01, 2023	BUY	$314.42 - $351.91 $2.51 Million - $2.81 Million	7,996 Added 5.77%	146,568 $51.6 Million
Q1 2023 May 03, 2023	BUY	$283.23 - $323.1 $5.51 Million - $6.29 Million	19,457 Added 16.33%	138,572 $43.7 Million
Q4 2022 Jan 31, 2023	BUY	$285.76 - $321.48 $17 Million - $19.1 Million	59,543 Added 99.95%	119,115 $34.4 Million
Q3 2022 Nov 08, 2022	BUY	$273.83 - $305.53 $12.6 Million - $14.1 Million	46,137 Added 343.41%	59,572 $17.2 Million
Q2 2022 Jul 20, 2022	SELL	$234.96 - $292.55 $184,208 - $229,359	-784 Reduced 5.51%	13,435 $3.79 Million
Q1 2022 May 03, 2022	BUY	$221.42 - $260.97 $151,008 - $177,981	682 Added 5.04%	14,219 $3.71 Million
Q4 2021 Jan 31, 2022	BUY	$177.01 - $223.45 $2.4 Million - $3.02 Million	13,537 New	13,537 $2.97 Million
Q4 2020 Feb 10, 2021	SELL	$207.01 - $276.09 $33 Million - $44.1 Million	-159,556 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$255.65 - $303.1 $4.88 Million - $5.78 Million	19,077 Added 13.58%	159,556 $43.4 Million
Q2 2020 Aug 07, 2020	BUY	$225.48 - $295.8 $357,611 - $469,138	1,586 Added 1.14%	140,479 $40.8 Million
Q1 2020 May 04, 2020	BUY	$199.77 - $247.81 $27.7 Million - $34.4 Million	138,893 New	138,893 $33 Million
Q2 2018 Jul 26, 2018	SELL	$145.72 - $169.96 $1.42 Million - $1.66 Million	-9,740 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$151.6 - $177.13 $256,204 - $299,349	1,690 Added 20.99%	9,740 $0
Q4 2017 Feb 12, 2018	BUY	$137.28 - $155.55 $104,332 - $118,218	760 Added 10.43%	8,050 $0
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $1.08 Million - $1.18 Million	7,290	7,290 $0

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cookson Peirce & CO Inc with notifications on news.

Account

Cookson Peirce & CO Inc Vertex Pharmaceuticals Inc Transaction History